Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
THY1 antisense RNA 1 (THY1-AS1, RP11-334E6.12) is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the THY1 locus. As a lncRNA, THY1-AS1 does not code for a protein but may regulate the expression of the adjacent THY1 gene or others, typically through epigenetic, transcriptional, or post-transcriptional mechanisms. No structured data or biological roles for THY1-AS1 are provided in the current search results, which focus exclusively on the protein-coding THY1 (CD90) and its roles in stem cells, immune regulation, cell adhesion, cancer, and fibrosis[1][2][3][4][5]. As such, functional, therapeutic, and clinical information specific to THY1-AS1 remains undetermined in these references.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on THY1 antisense RNA 1 (THY1-AS1).